EP1071405A1 - Methode zur behandlung von asthma - Google Patents

Methode zur behandlung von asthma

Info

Publication number
EP1071405A1
EP1071405A1 EP99918570A EP99918570A EP1071405A1 EP 1071405 A1 EP1071405 A1 EP 1071405A1 EP 99918570 A EP99918570 A EP 99918570A EP 99918570 A EP99918570 A EP 99918570A EP 1071405 A1 EP1071405 A1 EP 1071405A1
Authority
EP
European Patent Office
Prior art keywords
asthma
treatment
composition
esters
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99918570A
Other languages
English (en)
French (fr)
Inventor
Thomas Dosumu-Johnson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DOSUMU JOHNSON THOMAS
Original Assignee
DOSUMU JOHNSON THOMAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DOSUMU JOHNSON THOMAS filed Critical DOSUMU JOHNSON THOMAS
Publication of EP1071405A1 publication Critical patent/EP1071405A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
EP99918570A 1998-04-16 1999-04-15 Methode zur behandlung von asthma Withdrawn EP1071405A1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6149798A 1998-04-16 1998-04-16
US61497 1998-04-16
PCT/US1999/008226 WO1999052508A1 (en) 1998-04-16 1999-04-15 Method for the treatment of asthma

Publications (1)

Publication Number Publication Date
EP1071405A1 true EP1071405A1 (de) 2001-01-31

Family

ID=22036172

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99918570A Withdrawn EP1071405A1 (de) 1998-04-16 1999-04-15 Methode zur behandlung von asthma

Country Status (6)

Country Link
EP (1) EP1071405A1 (de)
JP (1) JP2002511401A (de)
AU (1) AU762102B2 (de)
CA (1) CA2328344A1 (de)
MX (1) MXPA00010103A (de)
WO (1) WO1999052508A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6417227B1 (en) * 1999-04-28 2002-07-09 Cg And Associates Methods of delivery of cetyl myristoleate
WO2001041783A1 (en) * 1999-12-09 2001-06-14 Bruce Levin Methods and compositions for treatment of inflammatory disease
US6677321B1 (en) 1999-12-09 2004-01-13 Bruce Levin Methods and compositions for treatment of inflammatory disease
US20030153620A1 (en) 2000-05-12 2003-08-14 Meakin Timothy David Treating eczema and/or psoriasis
ATE322256T1 (de) 2001-09-04 2006-04-15 Loders Croklaan Bv Zusammensetzung enthaltend einen substituirte fettsäure oder einen substituirte fettsäurederivate
NZ514536A (en) * 2001-09-28 2005-02-25 Meracol Corp Ltd Use of cetyl myristate and/or cetyl palmitate to treat asthma, chronic obstructive pulmonary disease and/or other respiratory difficulties
US7612111B2 (en) * 2003-03-20 2009-11-03 Imagenetix, Inc. Esterified fatty acid composition
NZ533370A (en) 2004-06-03 2006-11-30 Meracol Corp Ltd Use of cetyl myristate and cetyl palmitate in therapy for multiple sclerosis
US9511016B2 (en) * 2007-06-12 2016-12-06 Epicentrx, Inc. Topical composition for treating pain
CN110234315B (zh) * 2016-10-31 2023-04-21 克利夫兰诊所基金会 用于治疗病状的癸酸和肉豆蔻酸组合物
CN114544812B (zh) * 2022-02-18 2023-06-30 复旦大学附属中山医院 一种代谢组合式标志物在诊断哮喘中的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0733362A1 (de) * 1995-03-08 1996-09-25 Environmental Research Institute, Inc. Polynactine als antiallergische Mittel und IL-5-Hemmer

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9952508A1 *

Also Published As

Publication number Publication date
MXPA00010103A (es) 2002-08-06
WO1999052508A1 (en) 1999-10-21
JP2002511401A (ja) 2002-04-16
CA2328344A1 (en) 1999-10-21
AU762102B2 (en) 2003-06-19
AU3644999A (en) 1999-11-01

Similar Documents

Publication Publication Date Title
Vane et al. Inflammation and the mechanism of action of anti‐inflammatory drugs
KR100764329B1 (ko) 비염 및 결막염의 치료를 위한, 류코트리엔의 작용에영향을 미치는 물질과 비진정성 항히스타민제의 신규한배합물
Chanarin et al. Leukotrienes as a target in asthma therapy
AU762102B2 (en) Method for the treatment of asthma
US20090053143A1 (en) Liquid inhalation formulations of dehydroepiandrosterone derivatives
JPH0714873B2 (ja) 局所性製薬組成物
EP1655026B1 (de) Feste pharmazeutische Arzneimittelformulierung enthaltend Diacerein und Meloxicam
US5260335A (en) Pharmaceutical preparations for the treatment of inflammatory diseases
US20090042972A1 (en) Methods of using low-dose doxepin for the improvement of sleep
JP2016041757A (ja) 睡眠改善のための低用量ドキセピンの使用法
US6225342B1 (en) Use of calendula glycosides for the treatment of psoriasis
JPH11504941A (ja) タイプｉｉ糖尿病のピコリン酸クロム高用量治療
AU2002343270B2 (en) Treating asthma, chronic obstructive pulmonary disease and/or other respiratory difficulties
JP2008069143A (ja) 関節リウマチ治療用植物抽出物
US8637087B2 (en) Treatment of interstitial cystitis using (6aR, 10aR)-Δ8-tetrahydrocannabinol-11-OIC acids
WO2007055806A1 (en) Anti-emetic uses of (3r,4r)-δ8-tetrahydrocannabinol-11-oic acids
ITMI972690A1 (it) Uso di complessi di estratti vitis vinifera con fosfolipidi come agenti anti-arteriosclerotici
IE48246B1 (en) Sterolins and their use
KR100686297B1 (ko) 루코트리엔 저해물질과 혼합하여 테르페나딘 대사물질을이용하는 방법 및 조성물
WO2008010663A1 (en) Sophoricoside-containing composition for reducing body-weight or body-fat
CA2112195A1 (en) Preventive and therapeutic agent for arteriosclerosis
Crescioli et al. Controlled-Release Theophylline Inhibits Early Morning Airway Obstruction and Hyperresponsivenes in Asthmatic Subjects
CA2083611A1 (en) Use of platelet activating factor antagonists as anti-pruritic agents
Chung et al. New Drugs: Respiratory and allergic disease—I
CA1214393A (en) Composition useful in the treatment of diarrhea

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20001115

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20031101